E-mail

E-mail a Wiley Online Library Link

Atreya Dash, Joseph A. Pettus IV, Harry W. Herr, Bernard H. Bochner, Guido Dalbagni, S. Machele Donat, Paul Russo, Mary G. Boyle, Matthew I. Milowsky and Dean F. Bajorin A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder Cancer 113

Article first published online: 29 SEP 2008 | DOI: 10.1002/cncr.23848

Cisplatin and gemcitabine therapy for muscle-invasive bladder cancer produces definitive clinical activity in the neoadjuvant setting, with a pathological complete response rate similar to that of the standard methotrexate, vinblastine, doxorubicin, and cisplatin regimen and an excellent disease-free survival in responding patients.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field

SEARCH